| Year |
Citation |
Score |
| 2023 |
Pichichero ME. Variability of vaccine responsiveness in early life. Cellular Immunology. 104777. PMID 37866234 DOI: 10.1016/j.cellimm.2023.104777 |
0.304 |
|
| 2023 |
Shaffer M, Best K, Tang C, Liang X, Schulz S, Gonzalez E, White CH, Wyche TP, Kang J, Wesseling H, Topçuoğlu BD, Cairns T, Sana TR, Kaufhold RM, Maritz JM, ... ... Pichichero ME, et al. Very early life microbiome and metabolome correlates with primary vaccination variability in children. Msystems. e0066123. PMID 37610205 DOI: 10.1128/msystems.00661-23 |
0.329 |
|
| 2023 |
Kaur R, Mangiafesto J, Pryharski K, Rasam S, Zagursky R, Pichichero M. Expression conditions and characterization of a novelly-constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections. The Journal of Biological Chemistry. 105031. PMID 37437888 DOI: 10.1016/j.jbc.2023.105031 |
0.313 |
|
| 2022 |
Pichichero M, Malley R, Kaur R, Zagursky R, Anderson P. Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines. Expert Review of Vaccines. 22: 118-138. PMID 36565291 DOI: 10.1080/14760584.2023.2162506 |
0.347 |
|
| 2022 |
Michel LV, Kaur R, Gleghorn ML, Holmquist M, Pryharski K, Perdue J, Jones SP, Jackson N, Pilo I, Kasper A, Labbe N, Pichichero M. Haemophilus influenzae Protein D antibody suppression in a multi-component vaccine formulation. Febs Open Bio. PMID 36263849 DOI: 10.1002/2211-5463.13498 |
0.681 |
|
| 2022 |
Jones SP, Cook KH, Holmquist ML, Almekinder LJ, Delaney AM, Charles R, Labbe N, Perdue J, Jackson N, Pichichero ME, Kaur R, Michel LV, Gleghorn ML. Vaccine target and carrier molecule nontypeable Haemophilus influenzae protein D dimerizes like the close Escherichia coli GlpQ homolog but unlike other known homolog dimers. Proteins. PMID 36065600 DOI: 10.1002/prot.26418 |
0.666 |
|
| 2022 |
Chapman TJ, Pham M, Bajorski P, Pichichero ME. Antibiotic Use and Vaccine Antibody Levels. Pediatrics. 149. PMID 35474546 DOI: 10.1542/peds.2021-052061 |
0.329 |
|
| 2022 |
Kaur R, Pichichero M. Lipidation of Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection. Infection and Immunity. e0067821. PMID 35435727 DOI: 10.1128/iai.00678-21 |
0.342 |
|
| 2020 |
Michel LV, Gallardo L, Konovalova A, Bauer M, Jackson N, Zavorin M, McNamara C, Pierce J, Cheng S, Snyder E, Hellman J, Pichichero ME. Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli. International Journal of Antimicrobial Agents. 106163. PMID 32941946 DOI: 10.1016/J.Ijantimicag.2020.106163 |
0.641 |
|
| 2020 |
Kaur R, Pichichero M. Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine. Vaccine. 38: 4423-4431. PMID 32402752 DOI: 10.1016/J.Vaccine.2020.04.063 |
0.391 |
|
| 2019 |
Almudevar A, Kaur R, Pichichero M. Statistical projection of post-vaccination antibody kinetics between dosing schedules. Vaccine. PMID 31262582 DOI: 10.1016/J.Vaccine.2019.06.017 |
0.371 |
|
| 2019 |
Surendran N, Pichichero M. Genetically detoxified pertussis toxin induces superior antigen specific CD4 T cell responses compared to chemically detoxified pertussis toxin. Human Vaccines & Immunotherapeutics. PMID 30689515 DOI: 10.1080/21645515.2019.1565270 |
0.321 |
|
| 2018 |
Michel LV, Kaur R, Zavorin M, Pryharski K, Khan MN, LaClair C, O'Neil M, Xu Q, Pichichero ME. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice. Journal of Medical Microbiology. PMID 30136923 DOI: 10.1099/Jmm.0.000827 |
0.683 |
|
| 2018 |
Pichichero M, Kaur R, Scott DA, Gruber WC, Trammel J, Almudevar A, Center KJ. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study. The Lancet. Child & Adolescent Health. 2: 561-568. PMID 30119715 DOI: 10.1016/S2352-4642(18)30168-8 |
0.443 |
|
| 2017 |
Pichichero ME. Pneumococcal whole-cell and protein-based vaccines: changing the paradigm. Expert Review of Vaccines. 16: 1181-1190. PMID 29130395 DOI: 10.1080/14760584.2017.1393335 |
0.334 |
|
| 2017 |
Almudevar A, Pichichero ME. Modeling Specific Antibody Responses to Natural Immunization to Predict a Correlate of Protection Against Infection Before Commencing a Clinical Vaccine Trial. Human Vaccines & Immunotherapeutics. 0. PMID 28892455 DOI: 10.1080/21645515.2017.1329064 |
0.332 |
|
| 2017 |
Kaur R, Morris M, Pichichero ME. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era. Pediatrics. PMID 28784702 DOI: 10.1542/Peds.2017-0181 |
0.317 |
|
| 2017 |
Xu Q, Casey JR, Almudevar A, Pichichero ME. Correlation of Higher Antibody Levels to Pneumococcal Proteins with Protection from Pneumococcal Acute Otitis Media but not Protection from Nasopharyngeal Colonization in Young Children. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 28143785 DOI: 10.1016/J.Cmi.2017.01.011 |
0.321 |
|
| 2016 |
Xu Q, Pryharski K, Pichichero ME. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model. Vaccine. PMID 27919628 DOI: 10.1016/j.vaccine.2016.11.046 |
0.349 |
|
| 2016 |
Khan MN, Xu Q, Pichichero ME. Protection against Streptococcus pneumoniae invasive pathogenesis by a protein based vaccine is achieved by suppression of nasopharyngeal bacterial density during Influenza A virus co-infection. Infection and Immunity. PMID 27895132 DOI: 10.1128/IAI.00530-16 |
0.33 |
|
| 2016 |
Surendran N, Nicolosi T, Kaur R, Morris M, Pichichero M. Prospective study of the innate cellular immune response in low vaccine responder children. Innate Immunity. PMID 27864558 DOI: 10.1177/1753425916678471 |
0.384 |
|
| 2016 |
Surendran N, Nicolosi T, Pichichero M. Infants with low vaccine antibody responses have altered innate cytokine response. Vaccine. PMID 27745950 DOI: 10.1016/J.Vaccine.2016.09.050 |
0.368 |
|
| 2016 |
Kaur R, Casey JR, Pichichero ME. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015. The Pediatric Infectious Disease Journal. 35: 901-6. PMID 27420806 DOI: 10.1097/Inf.0000000000001206 |
0.332 |
|
| 2016 |
Pichichero ME. Ten Year Study of Acute Otitis Media in Rochester, NY. The Pediatric Infectious Disease Journal. PMID 27182898 DOI: 10.1097/INF.0000000000001216 |
0.312 |
|
| 2016 |
Khan MN, Ren D, Kaur R, Basha S, Zagursky R, Pichichero ME. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae. Expert Review of Vaccines. PMID 26894630 DOI: 10.1586/14760584.2016.1156539 |
0.377 |
|
| 2015 |
Pichichero ME, Khan MN, Xu Q. Next generation protein based Streptococcus pneumoniae vaccines. Human Vaccines & Immunotherapeutics. 0. PMID 26539741 DOI: 10.1080/21645515.2015.1052198 |
0.381 |
|
| 2015 |
Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Casey JR, Pichichero ME. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 33: 5809-14. PMID 26392013 DOI: 10.1016/J.Vaccine.2015.09.023 |
0.333 |
|
| 2015 |
Michel LV, Shaw J, MacPherson V, Barnard D, Bettinger J, D'Arcy B, Surendran N, Hellman J, Pichichero ME. Dual Orientation of the Outer Membrane Lipoprotein Pal in Escherichia coli. Microbiology (Reading, England). PMID 25808171 DOI: 10.1099/Mic.0.000084 |
0.644 |
|
| 2015 |
Xu Q, Surendran N, Verhoeven D, Klapa J, Ochs M, Pichichero ME. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis. Vaccine. 33: 993-1000. PMID 25597944 DOI: 10.1016/J.Vaccine.2015.01.014 |
0.368 |
|
| 2014 |
Khan MN, Pichichero ME. The host immune dynamics of pneumococcal colonization: implications for novel vaccine development. Human Vaccines & Immunotherapeutics. 10: 3688-99. PMID 25668673 DOI: 10.4161/21645515.2014.979631 |
0.314 |
|
| 2014 |
Kaur R, Pichichero M. Nasopharyngeal wash versus swab specimens for culture of nontypeable Haemophilus influenzae and other respiratory bacterial pathogens. The Journal of Infectious Diseases. 210: 1684-5. PMID 24864122 DOI: 10.1093/Infdis/Jiu309 |
0.326 |
|
| 2014 |
Verhoeven D, Perry S, Pichichero ME. Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge. Clinical and Vaccine Immunology : Cvi. 21: 1037-45. PMID 24850621 DOI: 10.1128/Cvi.00052-14 |
0.315 |
|
| 2014 |
Pichichero ME. Challenges in vaccination of neonates, infants and young children. Vaccine. 32: 3886-94. PMID 24837502 DOI: 10.1016/j.vaccine.2014.05.008 |
0.327 |
|
| 2014 |
Verhoeven D, Xu Q, Pichichero ME. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model. Vaccine. 32: 3205-10. PMID 24731814 DOI: 10.1016/J.Vaccine.2014.04.004 |
0.368 |
|
| 2014 |
Xu Q, Pichichero ME. Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children. Vaccine. 32: 706-11. PMID 24355091 DOI: 10.1016/j.vaccine.2013.11.096 |
0.346 |
|
| 2013 |
Pichichero ME, Casey JR, Almudevar A. Nonprotective responses to pediatric vaccines occur in children who are otitis prone. The Pediatric Infectious Disease Journal. 32: 1163-8. PMID 24141796 DOI: 10.1097/Inf.0B013E31829E887E |
0.347 |
|
| 2013 |
Pichichero ME. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Human Vaccines & Immunotherapeutics. 9: 2505-23. PMID 23955057 DOI: 10.4161/hv.26109 |
0.378 |
|
| 2013 |
Michel LV, Snyder J, Schmidt R, Milillo J, Grimaldi K, Kalmeta B, Khan MN, Sharma S, Wright LK, Pichichero ME. Dual orientation of the outer membrane lipoprotein P6 of nontypeable haemophilus influenzae. Journal of Bacteriology. 195: 3252-9. PMID 23687267 DOI: 10.1128/Jb.00185-13 |
0.686 |
|
| 2012 |
Khan MN, Kaur R, Pichichero ME. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children. Fems Immunology and Medical Microbiology. 65: 439-47. PMID 22463053 DOI: 10.1111/J.1574-695X.2012.00967.X |
0.334 |
|
| 2012 |
Khan MN, Pichichero ME. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine. 30: 2900-7. PMID 22349524 DOI: 10.1016/j.vaccine.2012.02.023 |
0.334 |
|
| 2012 |
Pichichero ME. Pneumococcal conjugate vaccines overview Pneumococcal Conjugate Vaccines. 9-17. DOI: 10.2217/EBO.11.310 |
0.318 |
|
| 2011 |
Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, Marshall GS, Catteau G, Dobbelaere K, Descamps D, Dubin G, Schuind A. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial. The Pediatric Infectious Disease Journal. 30: e225-34. PMID 21817954 DOI: 10.1097/Inf.0B013E31822D28Df |
0.309 |
|
| 2011 |
Chang A, Kaur R, Michel LV, Casey JR, Pichichero M. Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains. Human Vaccines. 7: 102-5. PMID 21285530 DOI: 10.4161/Hv.7.1.13351 |
0.696 |
|
| 2011 |
Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. American Journal of Obstetrics and Gynecology. 204: 334.e1-5. PMID 21272845 DOI: 10.1016/J.Ajog.2010.11.024 |
0.39 |
|
| 2011 |
Michel LV, Kalmeta B, McCreary M, Snyder J, Craig P, Pichichero ME. Vaccine candidate P6 of nontypable Haemophilus influenzae is not a transmembrane protein based on protein structural analysis. Vaccine. 29: 1624-7. PMID 21215345 DOI: 10.1016/J.Vaccine.2010.12.082 |
0.698 |
|
| 2010 |
Pichichero ME, Kaur R, Casey JR, Sabirov A, Khan MN, Almudevar A. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 28: 7184-92. PMID 20800701 DOI: 10.1016/J.Vaccine.2010.08.063 |
0.302 |
|
| 2010 |
Chang A, Adlowitz DG, Yellamatty E, Pichichero M. Haemophilus influenzae outer membrane protein P6 molecular characterization may not differentiate all strains of H. Influenzae from H. haemolyticus. Journal of Clinical Microbiology. 48: 3756-7. PMID 20686092 DOI: 10.1128/Jcm.01255-10 |
0.386 |
|
| 2010 |
Baxter R, Jeanfreau R, Block SL, Blatter M, Pichichero M, Jain VK, Dewé W, Innis BL. A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children. The Pediatric Infectious Disease Journal. 29: 924-30. PMID 20431425 DOI: 10.1097/INF.0b013e3181e075be |
0.33 |
|
| 2009 |
De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine. 27: 2877-83. PMID 19366579 DOI: 10.1016/j.vaccine.2009.02.102 |
0.347 |
|
| 2009 |
Arévalo MT, Xu Q, Paton JC, Hollingshead SK, Pichichero ME, Briles DE, Girgis N, Zeng M. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung. Fems Immunology and Medical Microbiology. 55: 346-51. PMID 19291171 DOI: 10.1111/J.1574-695X.2008.00518.X |
0.372 |
|
| 2009 |
Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Pediatrics. 123: 301-12. PMID 19117896 DOI: 10.1542/peds.2007-3317 |
0.328 |
|
| 2008 |
Pichichero ME. Improving vaccine delivery using novel adjuvant systems. Human Vaccines. 4: 262-70. PMID 18398303 |
0.305 |
|
| 2007 |
Denoël PA, Goldblatt D, de Vleeschauwer I, Jacquet JM, Pichichero ME, Poolman JT. Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines. Clinical and Vaccine Immunology : Cvi. 14: 1362-9. PMID 17699836 DOI: 10.1128/CVI.00154-07 |
0.35 |
|
| 2007 |
Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ. Immunogenicity and Safety of a Combination Diphtheria, Tetanus Toxoid, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine Coadministered with a 7-Valent Pneumococcal Conjugate Vaccine and a Haemophilus Influenzae Type b Conjugate Vaccine Journal of Pediatrics. 151: 43-49.e2. PMID 17586189 DOI: 10.1016/j.jpeds.2007.02.013 |
0.321 |
|
| 2007 |
Pichichero ME. The new meningococcal conjugate vaccine | Yeni konjuge meningokok a§isi Sendrom. 19: 72-77. |
0.307 |
|
| 2006 |
Pichichero M, Papa T, Blatter M, Mitchell D, Kratz R, Sneed J, Bassily E, Casey J, Gilmet G. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine Pediatric Infectious Disease Journal. 25: 995-1000. PMID 17072120 DOI: 10.1097/01.inf.0000243215.46312.4a |
0.311 |
|
| 2006 |
Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Pediatrics. 118: e602-9. PMID 16950952 DOI: 10.1542/peds.2005-2755 |
0.316 |
|
| 2006 |
Pichichero ME, Casey JR, Francis AB, Marsocci SM, Murphy M, Hoeger W, Cleary C. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: Safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules Clinical Pediatrics. 45: 613-620. PMID 16928838 DOI: 10.1177/0009922806289593 |
0.301 |
|
| 2006 |
Pichichero ME. The new meningococcal conjugate vaccine. A profile of its safety, efficacy, and indications for use Postgraduate Medicine.. 119: 47-54, 64. PMID 16913647 DOI: 10.3810/pgm.2006.06.1640 |
0.324 |
|
| 2006 |
Shinefield HR, Pichichero ME. Rotavirus vaccine (RotaTeq®): Profile report Drugs and Therapy Perspectives. 22: 5-6. DOI: 10.2165/00042310-200622100-00002 |
0.312 |
|
| 2006 |
Pichichero ME. Rotavirus vaccine (RotaTeq®): A viewpoint Pediatric Drugs. 8: 204. |
0.319 |
|
| 2005 |
Pichichero ME. Meningococcal conjugate vaccines Expert Opinion On Biological Therapy. 5: 1475-1489. PMID 16255651 DOI: 10.1517/14712598.5.11.1475 |
0.307 |
|
| 2005 |
Casey JR, Pichichero ME. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults Drugs. 65: 1367-1389. PMID 15977969 DOI: 10.2165/00003495-200565100-00005 |
0.344 |
|
| 2005 |
Pichichero M, Casey J, Blatter M, Rothstein E, Ryall R, Bybel M, Gilmet G, Papa T. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children Pediatric Infectious Disease Journal. 24: 57-62. PMID 15665711 DOI: 10.1097/01.inf.0000148928.10057.86 |
0.314 |
|
| 2004 |
Geier MR, Geier DA, Pichichero ME, Treanor J. Mercury in vaccines and potential conflicts of interest [4] (multiple letters) Lancet. 364: 1217-1218. PMID 15464179 DOI: 10.1016/S0140-6736(04)17134-1 |
0.301 |
|
| 2002 |
Novotny LA, Pichichero ME, Denoël PA, Neyt C, Vanderschrick S, Dequesne G, Bakaletz LO. Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media Vaccine. 20: 3590-3597. PMID 12297406 DOI: 10.1016/S0264-410X(02)00306-7 |
0.35 |
|
| 2002 |
Greenberg DP, Pickering LK, Senders SD, Bissey JD, Howard RA, Blatter MM, Reisinger K, Pichichero ME, Howe BJ. Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy. Pediatrics. 109: 666-72. PMID 11927713 DOI: 10.1542/peds.109.4.666 |
0.316 |
|
| 2001 |
Shelly MA, Pichichero ME, Treanor JJ. Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults. Scandinavian Journal of Infectious Diseases. 33: 542-4. PMID 11515767 DOI: 10.1080/00365540110026502 |
0.3 |
|
| 2001 |
Pichichero ME, Anderson EL, Rennels MB, Edwards KM, England JA. Fifth vaccination with diphtheria, tetanus and acellular pertussis is beneficial in four- to six-year-olds Pediatric Infectious Disease Journal. 20: 427-433. PMID 11332669 DOI: 10.1097/00006454-200104000-00011 |
0.306 |
|
| 2000 |
Rennels MB, Englund JA, Bernstein DI, Losonsky GA, Anderson EL, Pichichero ME, Munoz FM, Wolff MC. Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination. The Pediatric Infectious Disease Journal. 19: 417-23. PMID 10819337 DOI: 10.1097/00006454-200005000-00006 |
0.334 |
|
| 2000 |
Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics. 105: e11. PMID 10617748 DOI: 10.1542/peds.105.1.e11 |
0.313 |
|
| 1998 |
Pichichero ME, Passador S. Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 1378-84. PMID 9431382 DOI: 10.1086/516154 |
0.337 |
|
| 1997 |
Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics. 100: 772-88. PMID 9346976 DOI: 10.1542/peds.100.5.772 |
0.323 |
|
| 1997 |
Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, Meschievitz C, Daum RS. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants. The Pediatric Infectious Disease Journal. 16: 863-70. PMID 9306481 DOI: 10.1097/00006454-199709000-00009 |
0.329 |
|
| 1997 |
Pichichero ME. Acellular pertussis vaccines. Towards an improved safety profile. Drug Safety. 15: 311-24. PMID 8941493 DOI: 10.2165/00002018-199615050-00002 |
0.324 |
|
| 1996 |
Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy AM, Buscarino C. Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine. Scandinavian Journal of Infectious Diseases. 28: 159-63. PMID 8792483 DOI: 10.3109/00365549609049068 |
0.348 |
|
| 1996 |
Bernstein HH, Rothstein EP, Pichichero ME, Green JL, Reisinger KS, Blatter MM, Halpern J, Arbeter AM, Bernstein DI, Smith V. Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States. Vaccine. 13: 1631-5. PMID 8719512 DOI: 10.1016/0264-410X(95)00137-P |
0.333 |
|
| 1996 |
Pichichero ME, Shelly MA, Treanor JJ. EVALUATION OF A PENTAVALENT CONJUGATED PNEUMOCOCCAL VACCINE IN TODDLERS.▴ 1077 Pediatric Research. 39: 182-182. DOI: 10.1203/00006450-199604001-01099 |
0.307 |
|
| 1996 |
Pichichero ME, Passador S. RESPONSE TO AN HAEMOPHILUS INFLUENZAE B (HIB) CONJUGATE VACCINE BOOSTER FOLLOWING LOW ANTIBODY RESPONSES TO SIMULTANEOUS DTaP-HIB-HEPATITIS B COMBINATION VACCINE IN INFANTS. ▴ 1076 Pediatric Research. 39: 182-182. DOI: 10.1203/00006450-199604001-01098 |
0.301 |
|
| 1994 |
Annunziato PW, Rothstein EP, Bernstein HH, Blatter MM, Reisinger KS, Pichichero ME. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates. Archives of Pediatrics & Adolescent Medicine. 148: 503-7. PMID 8180641 DOI: 10.1001/archpedi.1994.02170050061011 |
0.319 |
|
| 1994 |
Pichichero ME, Green JL, Francis AB, Marsocci SM, Lynd AM, Litteer T. Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children. The Pediatric Infectious Disease Journal. 13: 193-6. PMID 8177626 DOI: 10.1097/00006454-199403000-00005 |
0.337 |
|
| 1993 |
Pichichero ME, Francis AB, Marsocci SM, Green JL, Disney FA. Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants. American Journal of Diseases of Children (1960). 147: 295-9. PMID 8438811 DOI: 10.1001/archpedi.1993.02160270057018 |
0.321 |
|
| 1993 |
Pichichero ME, Marsocci SM, Francis AB, Green JL, Disney FA, Rennels MB, Lewis ED, Sugarman L, Losonsky GA, Zito E. A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants. Vaccine. 11: 747-53. PMID 8393606 DOI: 10.1016/0264-410X(93)90260-5 |
0.333 |
|
| 1993 |
Pichichero ME, Losonsky GA. Asymptomatic infections due to wild-type rotavirus may prime for a heterotypic response to vaccination with rhesus rotavirus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 16: 86-92. PMID 8383548 DOI: 10.1093/clinids/16.1.86 |
0.333 |
|
| 1992 |
Bernstein HH, Rothstein EP, Pichichero ME, Francis AB, Kovel AJ, Disney FA, Green JL, Marsocci SM, Lynd AM, Wood GC. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children. American Journal of Diseases of Children (1960). 146: 556-9. PMID 1621656 DOI: 10.1001/archpedi.1992.02160170036012 |
0.315 |
|
| 1992 |
Madore HP, Christy C, Pichichero M, Long C, Pincus P, Vosefsky D, Kapikian AZ, Dolin R, Elmwood P. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants Journal of Infectious Diseases. 166: 235-243. PMID 1321858 DOI: 10.1093/Infdis/166.2.235 |
0.454 |
|
| 1991 |
Pichichero ME, Green JL, Francis AB, Marsocci SM, Disney FA. New vaccines and vaccination policies. Pediatric Annals. 19: 686-8, 690-1, 694. PMID 2177872 DOI: 10.3928/0090-4481-19901201-06 |
0.302 |
|
| 1989 |
Pichichero ME, Bracikowski A, Sullivan R, Madore D, Anderson P. Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine. The Pediatric Infectious Disease Journal. 8: 20-3. PMID 2784202 DOI: 10.1097/00006454-198901000-00007 |
0.34 |
|
| 1988 |
Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A, Dolin R. Field trial of rhesus rotavirus vaccine in infants. The Pediatric Infectious Disease Journal. 7: 645-50. PMID 2845349 DOI: 10.1097/00006454-198809000-00009 |
0.303 |
|
| 1987 |
Anderson P, Pichichero M, Edwards K, Porch CR, Insel R. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine The Journal of Pediatrics. 111: 644-650. PMID 3499499 DOI: 10.1016/S0022-3476(87)80237-8 |
0.419 |
|
| 1987 |
Pichichero ME, Badgett JT, Rodgers GC, McLinn S, Trevino-Scatterday B, Nelson JD. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children. The Pediatric Infectious Disease Journal. 6: 352-63. PMID 3495775 DOI: 10.1097/00006454-198704000-00004 |
0.376 |
|
| 1986 |
Pichichero ME, Barkin RM, Samuelson JS. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series. Pediatric Infectious Disease. 5: 428-30. PMID 3487779 DOI: 10.1097/00006454-198607000-00010 |
0.341 |
|
| 1984 |
Anderson PW, Pichichero ME. ANTIBODY (Ab) TO THE CAPSULAR POLYSACCHARIDE (PRP) OF HAEMOPHILUS INFLUENZAE B IN 2 TO 6-MO-OLD INFANTS VACCINATED WITH PRP OLIGOSACCHARIDES CONJUGATED TO THE DIPHTHERIA PROTEIN CRM197 Pediatric Research. 18: 252A-252A. DOI: 10.1203/00006450-198404001-00953 |
0.317 |
|
| Show low-probability matches. |